Pharma-Bio Serv (OTCMKTS:PBSV) Announces Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) announced its quarterly earnings results on Friday. The company reported $0.02 EPS for the quarter, meeting analysts’ consensus estimates of $0.02, Yahoo Finance reports. Pharma-Bio Serv had a return on equity of 7.91% and a net margin of 7.09%.

Pharma-Bio Serv Price Performance

Shares of OTCMKTS:PBSV opened at $0.98 on Friday. The firm has a market cap of $22.52 million, a P/E ratio of 16.33 and a beta of 0.41. Pharma-Bio Serv has a 12-month low of $0.68 and a 12-month high of $1.20. The business has a fifty day simple moving average of $0.96 and a 200 day simple moving average of $0.96.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in the United States and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies.

Further Reading

Earnings History for Pharma-Bio Serv (OTCMKTS:PBSV)

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with's FREE daily email newsletter.